Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for sickle cell disease.

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may ...

Charity Killing Cancer Kindly says synthetic these pills 'bombard the body with huge doses of wholly unnecessary nutrients' ...

Producers should regularly look at eyes during vaccination, weaning and other handling activities. Any individual cattle with abnormal eyes should be flagged for examination and possible treatment by ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ's dense tissue to define the margins between malignant and normal tissue. A new study uses DNA origami ...

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

Stem cells are often described as the body's master cells. Healthy stem cells can restore the blood system after cancer treatment.

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ's dense tissue to define the margins between malignant and normal tissue.